MINERALEX DIN 02244855
Health Canada record
| Active ingredient(s) | POTASSIUM (POTASSIUM CHLORIDE) 150 MG; CALCIUM (CALCIUM PHOSPHATE (DIBASIC)) 150 MG; MANGANESE (MANGANESE SULFATE) 7.5 MG; MAGNESIUM (MAGNESIUM OXIDE) 54 MG; ZINC (ZINC CITRATE) 4.95 MG; SILICON DIOXIDE 12 MG; SELENIUM (SELENIUM HVP CHELATE) 30 MCG; CHROMIUM (CHROMIUM HVP CHELATE) 60 MCG; MOLYBDENUM (MOLYBDENUM HVP CHELATE) 30 MCG |
|---|---|
| Dosage form | Liquid |
| Route | Oral |
| Schedule | NON-PRESCRIPTION DRUGS |
| Class | Human |
| ATC | |
| Original market date | 12-Nov-2001 |
| Current status date | 26-Jun-2008 |
| Source | Health Canada DPD |
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing POTASSIUM (POTASSIUM CHLORIDE)
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 00658367 | IODINE-POTASSIUM TABLETS | LE NATURISTE J.M.B. INC. | Tablet | POTASSIUM (POTASSIUM CHLORIDE) 75 MG; IODINE (POTASSIUM IODIDE) .15 MG | Cancelled Post Market |
| 00464813 | K LYTE CL PWR | BRISTOL LABS DIVISION OF BRISTOL-MYERS SQUIBB | Powder For Solution | POTASSIUM (POTASSIUM CHLORIDE) 1.86 G | Cancelled Post Market |
| 00553476 | POTASSIUM AND IODINE TAB | COUNTRY HEALTH LABORATORIES LTD. | Tablet | POTASSIUM (POTASSIUM CHLORIDE) 75 MG; IODINE (KELP) .15 MG | Cancelled Post Market |